Department of Justice, Maryland, Illinois, New Jersey, and New York, v. United Health and Amedisys
Date Filed: November 12, 2024Status: Pending
District Court: United States District Court for the District of Maryland – 1:24-cv-03267-JKB
Nature of Suit: Antitrust – Merger Challenge
Defendant Type: Provider
Plaintiff Type: Federal, State
Case Info: https://www.justice.gov/opa/pr/justice-department-sues-block-unitedhealth-groups-acquisition-home-health-and-hospice
The Justice Department, together with the Attorneys General of Maryland, Illinois, New Jersey, and New York, filed a civil antitrust lawsuit to block UnitedHealth Group Incorporated’s proposed $3.3 billion acquisition of rival home health and hospice services provider Amedisys Inc. (Amedisys) in the District of Maryland. The case alleges that the transaction would eliminate competition between UnitedHealth and Amedisys, two of the largest home health and hospice providers in the United States, and that eliminating the competition would harm patients who receive home health and hospice services, insurers who contract for home health services, and nurses who provide home health and hospice services.
According to the DOJ, UnitedHealth is a publicly traded Delaware corporation headquartered in Minnetonka, Minnesota. UnitedHealth is a vertically integrated insurer, healthcare provider, pharmacy benefit manager, and healthcare software and services vendor that brought in $372 billion in revenue in 2023. In 2022, before their company was acquired by UnitedHealth, LHC nurses and other healthcare professionals made approximately 12 million visits to patients in 37 states and the District of Columbia and earned over $2.3 billion in revenue. Amedisys is a home health and hospice services provider and a publicly traded Delaware corporation headquartered in Baton Rouge, Louisiana. In 2023, Amedisys nurses and other healthcare professionals made 10.6 million visits to patients in 37 states and the District of Columbia, earning the company $2.2 billion in revenue.
Leave A Comment